The National Institute of Allergy and Infectious Diseases (NIAID) Division of Allergy, Immunology and Transplantation (DAIT) has a requirement for developing products for treatment of radiation injuries from exposures due to a nuclear and radiological attacks.
NIAID is soliciting proposals for a contract entitled “Radiation/Nuclear Medical Countermeasure Product Development Support Services” to advance the development of candidate medical countermeasures (MCMs).
Research and development studies supported by this RFP will advance candidate MCMs to a stage where products are eligible for advanced product development by the Biomedical Advanced Research and Development Authority (BARDA) or acquisition under the Project BioShield Act of 2004.
It is anticipated that one Indefinite Delivery Indefinite Quantity type contract will be awarded for a 5-year period of performance beginning on or about August 1, 2015.
The Task Areas will include:
- Administrative and Technical Support
- Animal Model Development and Efficacy Testing of Candidate Medical Countermeasures
- Nonclinical Studies in Support of IND/NDA/BLA
- Phase I Clinical Studies
- Chemistry, Manufacturing and Control Support Services
The first Task Area is anticipated to encompass a cost-reimbursement, term (level of effort) Task Order and the others completion type cost reimbursement Task Orders. Options may be used to extend the period of performance of some Task Orders.
Further details are available under Solicitation Number: RFP-NIAID-DAIT-NIHAI2014005. The response deadline is December 1, 2014.
